Evidence map›Paper›PMID 41096900›Full record

ArticleInternational journal of molecular sciences2025

Improvement in Glucometric Outcomes After Control-IQ Initiation in Pediatric and Adolescent Type 1 Diabetes Patients: The Impact of Basal Time in Range.

Ana Gómez-Perea, Alfonso Lendínez-Jurado, Silvia Gallego-Gutiérrez, Fuensanta Guerrero-Del-Cueto, Ana García-Ruiz, Cristina López-De La Torre, Fernando Cardona-Díaz, Isabel Leiva-Gea

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana Gómez-PereaDepartment of Pediatric Endocrinology, Regional University Hospital of Málaga, 29011 Málaga, Spain.ORCID 0000-0002-2478-4212
Alfonso Lendínez-JuradoDepartment of Pediatric Endocrinology, Regional University Hospital of Málaga, 29011 Málaga, Spain.ORCID 0000-0003-4408-1335
Silvia Gallego-GutiérrezDepartment of Pediatric Endocrinology, Regional University Hospital of Málaga, 29011 Málaga, Spain.
Fuensanta Guerrero-Del-CuetoInstituto de Investigación Biomédica de Málaga (IBIMA)-Plataforma BIONAND, 29010 Málaga, Spain.ORCID 0000-0003-4065-8870
Ana García-RuizDistrito Sanitario Málaga-Guadalhorce, 29009 Málaga, Spain.
Cristina López-De La TorreDepartment of Biomedicine and Dentistry, Faculty of Biomedical Sciences and Sports, Universidad Europea de Andalucía, 29010 Málaga, Spain.ORCID 0009-0004-0732-6385
Fernando Cardona-DíazInstituto de Investigación Biomédica de Málaga (IBIMA)-Plataforma BIONAND, 29010 Málaga, Spain.ORCID 0000-0003-4460-6824
Isabel Leiva-GeaDepartment of Pediatric Endocrinology, Regional University Hospital of Málaga, 29011 Málaga, Spain.

Funding

Andalusian Ministry of Health and Family PIGE 0533-2019
6 · The paper itself

Abstract

The development of closed-loop systems represents an evolutionary advance in the management of patients with type 1 diabetes (T1D). This study aimed to analyze the impact of the Control-IQ advanced hybrid closed-loop (AHCL) system on glucometric outcomes in a pediatric and adolescent population with T1D, comparing results with baseline values and assessing the influence of baseline Time in Range (TIR) on glycemic control in children under 6 years old over a 12-month period. A 12-month prospective analysis was conducted in 26 patients with T1D (aged 2-15 years) initiating the Control-IQ system. Glucometric variables were assessed at baseline (before system implementation) and at 1, 3, 6, and 12 months post-implementation. A subgroup analysis was performed in patients under 6 years old (

Indexed as

Blood GlucoseDiabetes Mellitus, Type 1Glycemic ControlHypoglycemic AgentsInsulinInsulin Infusion SystemsAdolescentBlood Glucose Self-MonitoringChildChild, PreschoolFemaleHumansHyperglycemiaMaleProspective StudiesTreatment OutcomeBlood GlucoseHypoglycemic AgentsInsulinadvanced hybrid closed-looppediatric type 1 diabetesTandem Control-IQtime in hyperglycemiatime in hypoglycemiatime in range

Identifiers

PMID41096900
PMCPMC12524478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.